Intracellular complement proteins are tumor-promoting effectors and poor prognosis biomarkers in renal cancer

نویسندگان

چکیده

Abstract Clear cell renal carcinoma (ccRCC) tumors highly express proteins of the complement system, a major innate immune defense mechanism. Exploring spatial transcriptome and making an atlas staining patterns by ultra-high multiplex imaging ccRCC tumor sections, we revealed presence regions with co-regulated overexpression components, including C3 Factor H (FH). The strong for these correlated poor prognosis in patient cohort. These interacted physically lysosomes cells situ, as evidenced proximity ligation assay. We discovered previously unrecognized intracellular functions FH cells. knockdown resulted formation more compact tumorospheres than control hampered energy metabolism, while perturbed sphere-forming capacity due to decreased viability proliferation enhanced Krebs cycle. For two act together intracellularly, being negative regulator C3. also function independently each other, regulating gene transcription. interactome mass spectrometry, found that transcription factors regulate cycle proteins, controlling actin cytoskeleton remodeling, explaining altered morphology reduced motility FH-deficient In conclusion, are multitasking effectors, impacting multiple hallmarks cancer - enabling replicative immortality, stimulating proliferation, resisting death, deregulating cellular bearing potential new therapeutic targets. main author was supported DFF-1025-00015B Independent Research Fund Denmark (IRFD or DFF)

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Overexpression of GRK3, Promoting Tumor Proliferation, Is Predictive of Poor Prognosis in Colon Cancer

Deregulation of G protein-coupled receptor kinase 3 (GRK3), which belongs to a subfamily of kinases called GRKs, acts as a promoter mechanism in some cancer types. Our study found that GRK3 was significantly overexpressed in 162 pairs of colon cancer tissues than in the matched noncancerous mucosa (P < 0.01). Based on immunohistochemistry staining of TMAs, GRK3 was dramatically stained positive...

متن کامل

Positive ALDH1A3 and Negative GPX3 Expressions Are Biomarkers for Poor Prognosis of Gallbladder Cancer

BACKGROUND Gallbladder cancers (GBCs) are highly aggressive cancers with high mortality. However, biological markers for the progression and prognosis of GBC are currently unavailable in the clinic. OBJECTIVE To identify biomarkers for predicting GBC metastasis and prognosis. METHODS We examined ALDH1A3 and GPX3 expressions in 46 squamous cell/adenosquamous carcinomas (SC/ASC) and 80 adenoc...

متن کامل

Immunoglobulin free light chains are biomarkers of poor prognosis in basal-like breast cancer and are potential targets in tumor-associated inflammation

Inflammation is an important component of various cancers and its inflammatory cells and mediators have been shown to have prognostic potential. Tumor-infiltrating mast cells can promote tumor growth and angiogenesis, but the mechanism of mast cell activation is unclear. In earlier studies, we demonstrated that immunoglobulin free light chains (FLC) can trigger mast cells in an antigen-specific...

متن کامل

MMP16 is a marker of poor prognosis in gastric cancer promoting proliferation and invasion

Matrix metalloproteinases (MMPs) are closely associated with tumor proliferation, invasion and metastasis. In this study, we determined the MMPs expression and their clinical significances in gastric cancer (GC). We first extensive studied MMPs expression in GC in The Cancer Genome Atlas (TCGA) RNA sequence database and found MMP16 was candidate biomarker in GC. Then we validated clinical signi...

متن کامل

Immune Responses to Cancer: Are They Potential Biomarkers of Prognosis?

Recent technical improvements in evaluations of immune cells in situ and immune monitoring of patients with cancer have provided a wealth of new data confirming that immune cells play a key role in human cancer progression. This, in turn, has revived the expectation that immune endpoints might serve as reliable biomarkers of outcome or response to therapy in cancer. The recent successes in link...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Journal of Immunology

سال: 2023

ISSN: ['1550-6606', '0022-1767']

DOI: https://doi.org/10.4049/jimmunol.210.supp.71.37